Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 21, 2011

Mast cells in atherosclerosis as a source of the cytokine RANKL

  • Ahmed Salem Ali , Anna-Satina Lax , Mikko Liljeström , Ilari Paakkari , Nureddin Ashammakhi , Petri T. Kovanen and Yrjö T. Konttinen

Corresponding author: Yrjö T. Konttinen, MD, PhD, Biomedicum, P.O. Box 700, 00029 HUS, Finland Phone: +358-9-19125210, Fax: +358-9-19125218,

References

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685–95.10.1056/NEJMra043430Search in Google Scholar

2. Kaartinen M, Penttila A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994; 90:1669–78.10.1161/01.CIR.90.4.1669Search in Google Scholar

3. Schoppet M, Schaefer JR, Hofbauer LC. Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men [author reply e76]. Circulation 2003; 107:e76.10.1161/01.CIR.0000060815.25798.02Search in Google Scholar

4. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001; 21:1998–2003.10.1161/hq1201.100229Search in Google Scholar

5. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002; 22:549–53.10.1161/01.ATV.0000012303.37971.DASearch in Google Scholar

6. Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 2000; 192:463–74.10.1084/jem.192.4.463Search in Google Scholar

7. Lusis AJ. Atherosclerosis. Nature 2000; 407:233–41.10.1038/35025203Search in Google Scholar

8. Ueland T, Yndestad A, Oie E, Florholmen G, Halvorsen B, Froland SS. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation 2005; 111:2461–8.10.1161/01.CIR.0000165119.62099.14Search in Google Scholar

9. Jeziorska M, McCollum C, Wooley DE. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Arch 1998; 433:559–65.10.1007/s004280050289Search in Google Scholar

10. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 1994; 269:18134–40.10.1016/S0021-9258(17)32427-4Search in Google Scholar

Published Online: 2011-9-21
Published in Print: 2006-5-1

©2006 by Walter de Gruyter Berlin New York

Downloaded on 18.5.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2006.117/html
Scroll to top button